Skip to main content

Amerise Biosciences Ltd. (AMERISE.BO)

Bombay Stock Exchange (India) Financial Services Financial - ConglomeratesView data quality →
33.9Poor

ValueMarkers Composite Index

Top 1%#44,299 of 44,707

DCF data not available

Piotroski
0/9
Weak
Beneish
-
Altman
0.22
Distress
DCF Value
-
Overvalued
ROIC
-4.3%
Low
P/E
69.9
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Amerise Biosciences Ltd. (AMERISE.BO) — VMCI valuation read

Composite valuation read on AMERISE.BO: VMCI 34/100 against a Financial Services sector median of 50. The 16-point below-median print is the headline number for Amerise Biosciences Ltd., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for AMERISE.BO: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on AMERISE.BO: AMERISE.BO trades at 21.0x earnings, 17% above the Financial Services median of 18.0x; ROIC of 17.0% sits 7.0pp above the Financial Services median (10.0%); net debt to EBITDA of 3.5x is the binding constraint on the bear case. EV/EBITDA at 14.0x versus 12.0x for Financial Services closes the value frame.

AMERISE.BO fell 0.6% over the trailing 7 days, with a -6.5% read on a 30-day basis.

Amerise Biosciences Ltd. engages in the manufacture of plastic products. It does not have any current business activity. The company was founded on August 27, 1984 and is headquartered in Ahmedabad, India.

CEO: Albert HinesINwww.amradeepindustries.tech

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in AMERISE.BO’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.